These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6873 related articles for article (PubMed ID: 11299792)

  • 1. Antiproliferative efficacy of the somatostatin analogue TT-232 in human melanoma cells and tumours.
    Schwab RE; Froidevaux S; Paku S; Tejeda M; Szende B; Pap A; Beglinger C; Eberle AN; Kéri G
    Anticancer Res; 2001; 21(1A):71-5. PubMed ID: 11299792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor models.
    Tejeda M; Gaál D; Hullán L; Schwab R; Szokoloczi O; Kéri G
    Anticancer Res; 2007; 27(6B):4015-9. PubMed ID: 18225564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous administration of the somatostatin structural derivative /TT-232/ by subcutaneously implanted osmotic pump improves the efficacy and potency of antitumor therapy in different mouse and human tumor models.
    Tejeda M; Gaal D; Hullán L; Csuka O; Schwab R; Szokoloczi O; Kéri GY
    Anticancer Res; 2008; 28(5A):2769-74. PubMed ID: 19035308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.
    Tejeda M; Gaal D; Barna K; Csuka O; Kéri G
    Anticancer Res; 2003; 23(5A):4061-6. PubMed ID: 14666719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models.
    Tejeda M; Gaál D; Hullán L; Hegymegi-Barakonyi B; Kéri G
    Anticancer Res; 2006; 26(5A):3477-83. PubMed ID: 17094470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the tumor growth inhibitory effect of intermittent and continuous administration of the somatostatin structural derivative TT-232 in various human tumor models.
    Tejeda M; Gaál D; Hullán L; Csuka O; Schwab R; Szokoloczi O; Kéri G
    Anticancer Res; 2006; 26(4B):3011-5. PubMed ID: 16886628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232.
    Diaconu CC; Szathmári M; Kéri G; Venetianer A
    Br J Cancer; 1999 Jun; 80(8):1197-203. PubMed ID: 10376972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antitumor activity of TT-232 a novel somatostatin analog.
    Tejeda M; Gaal D; Schwab RE; Pap A; Keri G
    Anticancer Res; 1999; 19(4B):3265-8. PubMed ID: 10652622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibitory effect of the somatostatin structural derivative (TT-232) on leukemia models.
    Tejeda M; Gaál D; Csuka O; Kéri G
    Anticancer Res; 2005; 25(1A):325-30. PubMed ID: 15816555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of various administration routes on the antitumor efficacy ofTT-232, a novel somatostatin analog.
    Tejeda M; Gaal D; Schwab RE; Pap A; Szúts T; Keri G
    Anticancer Res; 2000; 20(2A):1023-7. PubMed ID: 10810391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.
    Pellizzari Tregno F; Sau A; Pezzola S; Geroni C; Lapenta C; Spada M; Filomeni G; Bonanno E; Federici G; Caccuri AM
    Eur J Cancer; 2009 Sep; 45(14):2606-17. PubMed ID: 19665369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism.
    Giammarioli AM; Maselli A; Casagrande A; Gambardella L; Gallina A; Spada M; Giovannetti A; Proietti E; Malorni W; Pierdominici M
    Cancer Res; 2008 Jul; 68(13):5291-300. PubMed ID: 18593930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia.
    Pintér E; Helyes Z; Németh J; Pórszász R; Pethö G; Thán M; Kéri G; Horváth A; Jakab B; Szolcsányi J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):142-50. PubMed ID: 12122501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
    Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M
    J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
    Humer J; Ferko B; Waltenberger A; Rapberger R; Pehamberger H; Muster T
    Melanoma Res; 2008 Oct; 18(5):314-21. PubMed ID: 18781129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R; Carbone R; Reiss M; Lacy J
    Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
    Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
    J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 344.